AOTI expects to report half-year revenue of at least USD31 million, up at least 18% from USD26.3 million in the first half of 2024.

Looking ahead, Portmeirion expects "modest" sales growth during its second half, due to "short term caution" on the US market. It anticipates flat to low single digit growth in the UK, as well as ...

(Alliance News) - Allergy Therapeutics PLC on Monday said it expects to report a small decline in earnings during its most recent financial year, as a result of regulatory changes within its key ...